Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza vaccine efficacy in adults with cancer receiving chemotherapy
ACTRN12611000306910Phase 2Not yet recruiting
- Sponsor
- Flinders Medical Centre
- Start
- Mar 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Butantan Influenza Trivalent, Fragmented and Inactivated in influenza, sponsored by Flinders Medical Centre. Primary endpoint: Seroconversion rate. Planned start Mar 2011; status: not yet recruiting.
02
Drugs
Butantan Influenza Trivalent, Fragmented and Inactivated
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12611000306910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000306910.